AI Predictive Biomarkers
Systemic disease risk prediction (e.g., cardiovascular, neurological)
Key Facts
About Eyenuk
Eyenuk is a pioneering, commercial-stage AI diagnostics company focused on preventing vision loss through autonomous eye screening. Its core technology, the EyeArt system, is the world's most extensively validated AI for diabetic retinopathy detection and holds the distinction of being the first with multiple camera clearances from the FDA and the first EU MDR certification for autonomous AI detection of DR, AMD, and glaucoma. The company is transitioning its leadership and has secured a landmark national health system deployment, positioning it for significant scale in addressing the massive global backlog of undiagnosed eye disease. Eyenuk operates as a private company, generating revenue through its diagnostic platform and services.
View full company profile